Dynamic Technology Lab’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Dynamic Technology Lab’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,680	Closed	-$341K	–	1611
2022 Q2	$341K	Buy	+7,680	New	+$353K	0.04%	722
2021 Q2	–	Sell	-6,802	Closed	-$284K	–	1627
2021 Q1	$284K	Buy	+6,802	New	+$316K	0.03%	814
2017 Q4	–	Sell	-4,300	Closed	-$257K	–	1402
2017 Q3	$257K	Buy	+4,300	New	+$260K	0.04%	800
2017 Q1	–	Sell	-2,554	Closed	-$203K	–	1324
2016 Q4	$203K	Buy	+2,554	New	+$186K	0.05%	721

Other funds holding EGRX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dynamic Technology Lab's EGRX Position: Q3 2022 in Review

Dynamic Technology Lab sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2022, closing a stake of 7,680 shares — an estimated $341K sold.

Dynamic Technology Lab first reported a position in EGRX in Q4 2016 and held it in 4 quarters. The position peaked at $341K in Q2 2022. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.

Dynamic Technology Lab reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Dynamic Technology Lab sold 7,680 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $341K.
Dynamic Technology Lab first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
Dynamic Technology Lab's Eagle Pharmaceuticals, Inc. position peaked at $341K in Q2 2022.
153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.

Based on Dynamic Technology Lab's 13F filing for Q3 2022, filed 14 Nov 2022.